AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22465220 — intervention group
Group type: EXPERIMENTAL
Intervention: Total urinary resveratrol metabolites (TRMs)
Number of subjects: 1000
Study 22465220 — intervention group
Group type: EXPERIMENTAL
Intervention: TRMs adjusted for alcohol
Number of subjects: 1000
Study 20037568 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBM) 300-1600 mg/day (mean 700±120 mg/day) for 25.43±2.34 months
Number of subjects: 48
Study 20037568 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OCB) 600-1800 mg/day (mean 900±145 mg/day) for 12±0.65 months
Number of subjects: 48
Study 20037568 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBM)
Number of subjects: 48
Study 20037568 — intervention group
Group type: COMPARATOR
Intervention: Oxcarbazepine (OCB)
Number of subjects: 48
Study 17324224 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg levetiracetam
Number of subjects: 26
Study 17324224 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg levetiracetam
Number of subjects: 26
Study 15505444 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at a target concentration of 3 microg/ml
Number of subjects: 40
Study 15505444 — intervention group
Group type: COMPARATOR
Intervention: Propofol titrated to maintain a BIS value of 40-50
Number of subjects: 40
Study 11581136 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent placement
Number of subjects: 381
Study 11581136 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 381
Study 9768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study 9768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus alfentanil 50 ng/mL
Number of subjects: 40
Study 9768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus alfentanil 100 ng/mL
Number of subjects: 40
Study 9768800 — intervention group
Group type: COMPARATOR
Intervention: Control (no alfentanil)
Number of subjects: 40
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 0
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's acetate solution
Number of subjects: 0
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Trometamol (tris)
Number of subjects: 0
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbicarb
Number of subjects: 0
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Tris buffer mixture (Tribonate)
Number of subjects: 0
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate and tris buffer mixture
Number of subjects: 0
Study 7924364 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffers that were not producing CO2
Number of subjects: 0
Study 3241274 — intervention group
Group type: EXPERIMENTAL
Intervention: CaCO3 at 20 mmol/day
Number of subjects: 12
Study 3241274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31901097 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 31190657 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic and anthropometric characteristics
Number of subjects: 678
Study 31190657 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 678
Study 31190657 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite, age, BMI, marital status
Number of subjects: 678
Study 27799020 — intervention group
Group type: EXPERIMENTAL
Intervention: Any psychotherapy services
Number of subjects: 6884
Study 27799020 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual psychotherapy services
Number of subjects: 6884
Study 25618173 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegafur gimeracil oteracil combined with THP and DDP
Number of subjects: 70
Study 25618173 — intervention group
Group type: COMPARATOR
Intervention: THP and DDP (Control)
Number of subjects: 70
Study 23272664 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity aerobic interval training (AIT) at 90% of max HR for 4×4 minutes, three times per week for 10 weeks
Number of subjects: 17
Study 23272664 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate continuous training (MCT) at 70% of max HR for 47 minutes, three times per week for 10 weeks
Number of subjects: 17
Study 23272664 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (age- and sex-matched individuals)
Number of subjects: 17
Study 21700302 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise combined with a low-sugar diet
Number of subjects: 75
Study 21700302 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise combined with a low-sugar diet
Number of subjects: 75
Study 21700302 — intervention group
Group type: COMPARATOR
Intervention: Standard low-fat diet with daily walking (control)
Number of subjects: 75
Study 21700302 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 75
Study 18190687 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients indicating interest in speaking to a specialist smoking adviser
Number of subjects: 6856
Study 18190687 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status measured by the Townsend Index
Number of subjects: 6856
Study 18190687 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded smoking status
Number of subjects: 6856
Study 18190687 — intervention group
Group type: EXPERIMENTAL
Intervention: Respondents with no recorded smoking status
Number of subjects: 6856
Study 18190687 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded smokers who responded to the questionnaire
Number of subjects: 6856
Study 17140886 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridging fibrosis
Number of subjects: 1016
Study 17140886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis
Number of subjects: 1016
Study 17140886 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count >150,000/mm(3)
Number of subjects: 1016
Study 17140886 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower platelet count, higher bilirubin, and INR
Number of subjects: 1016
Study 17140886 — intervention group
Group type: EXPERIMENTAL
Intervention: African American race and female sex
Number of subjects: 1016
Study 14572503 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (with or without alcohol)
Number of subjects: 24
Study 14572503 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (with or without temazepam)
Number of subjects: 24
Study 14572503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 14572503 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol only
Number of subjects: 24
Study 14572503 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam only
Number of subjects: 24
Study 14572503 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and temazepam combined
Number of subjects: 24
Study 10671807 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (walking 3 days/week at 70% HRR, starting at 20 min and increasing to 50 min by week 3)
Number of subjects: 29
Study 10671807 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained normal activity)
Number of subjects: 29
Study 9083908 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily (days 0-28) plus amoxycillin 500 mg three times daily (days 15-28)
Number of subjects: 101
Study 9083908 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matched to amoxycillin) three times a day (days 0-14) followed by placebo (days 15-28)
Number of subjects: 101
Study 9083908 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole plus amoxycillin
Number of subjects: 101
Study 8472521 — intervention group
Group type: EXPERIMENTAL
Intervention: ST-679 (1200 mg single oral dose)
Number of subjects: 40
Study 8472521 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (1000 mg single oral dose)
Number of subjects: 40
Study 3704665 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomy alone
Number of subjects: 1000
Study 3704665 — intervention group
Group type: COMPARATOR
Intervention: Myelosuppressive agents (32P or chlorambucil) supplemented by phlebotomy
Number of subjects: 1000
Study 29456079 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2a + placebo
Number of subjects: 280
Study 29456079 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2a + ETV
Number of subjects: 280
Study 29456079 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN alfa‐2a + ADV
Number of subjects: 280
Study 26962303 — intervention group
Group type: EXPERIMENTAL
Intervention: MIPS
Number of subjects: 12
Study 26341154 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Gufoni maneuver (faster position changing within 1s)
Number of subjects: 50
Study 26341154 — intervention group
Group type: COMPARATOR
Intervention: Non-accelerated Gufoni maneuver (slower maneuvers)
Number of subjects: 50
Study 24045030 — intervention group
Group type: EXPERIMENTAL
Intervention: Days of heroin use in the last month
Number of subjects: 112
Study 24045030 — intervention group
Group type: COMPARATOR
Intervention: Cocaine, cannabis, cigarettes, alcohol use, unintentional overdose, injection drug use
Number of subjects: 112
Study 19945275 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3mg i.v.
Number of subjects: 80
Study 19945275 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 8 mg i.v.
Number of subjects: 80
Study 19083391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate juice (250 mL daily for 4 weeks)
Number of subjects: 26
Study 19083391 — intervention group
Group type: COMPARATOR
Intervention: Apple juice (250 mL daily for 4 weeks)
Number of subjects: 26
Study 16176059 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban females
Number of subjects: 1700
Study 16176059 — intervention group
Group type: COMPARATOR
Intervention: Rural females
Number of subjects: 1700
Study 12614835 — intervention group
Group type: EXPERIMENTAL
Intervention: group‐based cognitive‐behavioral stress management/expressive‐supportive therapy intervention (CBSM+)
Number of subjects: 330
Study 12614835 — intervention group
Group type: COMPARATOR
Intervention: individual psychoeducation condition
Number of subjects: 330
Study 10852273 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injections (40 mg of 6‐methylprednisolone acetate)
Number of subjects: 20
Study 10852273 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 ml saline solution)
Number of subjects: 20
Study 9165957 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane in nitrous oxide and oxygen
Number of subjects: 0
Study 9165957 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane in oxygen alone
Number of subjects: 0
Study 9165957 — intervention group
Group type: COMPARATOR
Intervention: Propofol infusion
Number of subjects: 0
Study 1376797 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (ISR)
Number of subjects: 9
Study 1376797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2932722 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated analyser for bacterial identification and susceptibility testing
Number of subjects: 0
Study 2932722 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimizing information transfer from laboratory to ward
Number of subjects: 0
Study 2932722 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier results of susceptibility testing
Number of subjects: 0
Study 29088030 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual mass azithromycin distribution (6 distributions to children <12 years of age)
Number of subjects: 24
Study 29088030 — intervention group
Group type: COMPARATOR
Intervention: Annual mass azithromycin distribution (3 distributions to the entire community)
Number of subjects: 24
Study 27931257 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish program (semi-annual applications since age 1)
Number of subjects: 507
Study 27931257 — intervention group
Group type: COMPARATOR
Intervention: Standard oral health program (without fluoride varnish)
Number of subjects: 507
Study 27931257 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries presence
Number of subjects: 507
Study 27931257 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries-free children
Number of subjects: 507
Study 24666361 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tretinoin cream 0.1%
Number of subjects: 324
Study 22519942 — intervention group
Group type: EXPERIMENTAL
Intervention: Dräger V500 ventilator interface
Number of subjects: 0
Study 22519942 — intervention group
Group type: COMPARATOR
Intervention: Dräger Evita 4 ventilator interface
Number of subjects: 0
Study 22519942 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific training episode
Number of subjects: 0
Study 20230295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency magnetic field exposure in healthy subjects
Number of subjects: 81
Study 20230295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency magnetic field exposure in diabetic patients
Number of subjects: 81
Study 20230295 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure in diabetic patients
Number of subjects: 81
Study 17999710 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacing-induced heart rate changes in CAD patients
Number of subjects: 45
Study 17999710 — intervention group
Group type: COMPARATOR
Intervention: Pacing-induced heart rate changes in non-CAD patients
Number of subjects: 45
Study 17999710 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of myocardial ischemia using STC-VM
Number of subjects: 45
Study 17999710 — intervention group
Group type: EXPERIMENTAL
Intervention: STC-VM at 54 microV
Number of subjects: 45
Study 11732859 — intervention group
Group type: EXPERIMENTAL
Intervention: T/T genotype of the 5-HT2A receptor gene
Number of subjects: 58
Study 11732859 — intervention group
Group type: COMPARATOR
Intervention: C/C and C/T genotypes of the 5-HT2A receptor gene
Number of subjects: 58
Study 9231537 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated voice‐interactive program (CES-D) via cellular telephone
Number of subjects: 55
Study 9231537 — intervention group
Group type: COMPARATOR
Intervention: Face‐to‐face method (CES-D)
Number of subjects: 55
Study 9231537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods (CES-D)
Number of subjects: 55
Study 9231537 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated CES-D
Number of subjects: 55
Study 9231537 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal response latency time
Number of subjects: 55
Study 9231537 — intervention group
Group type: EXPERIMENTAL
Intervention: Acculturation levels of Spanish speakers
Number of subjects: 55
Study 8231041 — intervention group
Group type: EXPERIMENTAL
Intervention: IOL with laser ridge
Number of subjects: 100
Study 8231041 — intervention group
Group type: COMPARATOR
Intervention: IOL without laser ridge
Number of subjects: 100
Study 2891519 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal treatment (LH‐RH, LH‐RH plus hCG)
Number of subjects: 37
Study 2891519 — intervention group
Group type: EXPERIMENTAL
Intervention: New course of hCG
Number of subjects: 37
Study 30854987 — intervention group
Group type: EXPERIMENTAL
Intervention: Life History Calendar (LHC)
Number of subjects: 1000
Study 30854987 — intervention group
Group type: COMPARATOR
Intervention: Standard retrospective diagnostic interview without LHC
Number of subjects: 1000
Study 30324710 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based social skills training SOSTA-FRA
Number of subjects: 0
Study 30324710 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 27314247 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry extract (PAC‐Aproanthocyanidin‐A), 36 patients, administered for 12 weeks
Number of subjects: 72
Study 27314247 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 36 patients, administered for 12 weeks
Number of subjects: 72
Study 25604206 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended Internet-based intervention
Number of subjects: 0
Study 25604206 — intervention group
Group type: COMPARATOR
Intervention: Minimal Internet-based intervention
Number of subjects: 0
Study 23674791 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-bolus spectral CT protocol (60 keV)
Number of subjects: 163
Study 23674791 — intervention group
Group type: COMPARATOR
Intervention: Standard CT protocol (pancreatic phase)
Number of subjects: 163
Study 23674791 — intervention group
Group type: COMPARATOR
Intervention: Standard CT protocol (portal venous phase)
Number of subjects: 163
Study 23674791 — intervention group
Group type: COMPARATOR
Intervention: Standard CT protocol
Number of subjects: 163
Study 23674791 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-bolus spectral CT protocol
Number of subjects: 163
Study 20873899 — intervention group
Group type: EXPERIMENTAL
Intervention: Last-session alliances
Number of subjects: 250
Study 20873899 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-session alliances
Number of subjects: 250
Study 20873899 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple alliances that started over the mean and increased
Number of subjects: 250
Study 18853053 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine 3% associated with felypressin 0.03 IU/ml
Number of subjects: 65
Study 18853053 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 2% without vasoconstrictor
Number of subjects: 65
Study 16801691 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-Stirrup brace combined with elastic wrap
Number of subjects: 0
Study 16801691 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-Stirrup brace or walking cast for 10 days followed by bracing
Number of subjects: 0
Study 16801691 — intervention group
Group type: COMPARATOR
Intervention: All treatments (Air-Stirrup brace, elastic wrap, walking cast)
Number of subjects: 0
Study 12891281 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/day
Number of subjects: 90
Study 12891281 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 90
Study 12891281 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40 mg/day
Number of subjects: 90
Study 12891281 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (combined 10 mg and 40 mg)
Number of subjects: 90
Study 10974131 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 microg of testosterone per day transdermally
Number of subjects: 75
Study 10974131 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 microg of testosterone per day transdermally
Number of subjects: 75
Study 10974131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 8604904 — intervention group
Group type: EXPERIMENTAL
Intervention: Open tension-free hernioplasty procedure
Number of subjects: 2953
Study 8604904 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic repair
Number of subjects: 2953
Study 1593412 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsated jet irrigator with saline solution
Number of subjects: 10
Study 1593412 — intervention group
Group type: COMPARATOR
Intervention: Syringe with saline solution
Number of subjects: 10
Study 31321423 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete substitution (CS; 'avoid cigarettes')
Number of subjects: 150
Study 31321423 — intervention group
Group type: COMPARATOR
Intervention: Partial substitution (PS; 'use snus as you like with your cigarettes')
Number of subjects: 150
Study 31321423 — intervention group
Group type: COMPARATOR
Intervention: Usual brand cigarettes (UB)
Number of subjects: 150
Study 31321423 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete substitution (CS)
Number of subjects: 150
Study 31321423 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 150
Study 30728061 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus Aurantium + Caffeine (CA + C) 100 mg of CA and 100 mg of C
Number of subjects: 10
Study 30728061 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 10
Study 30728061 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus Aurantium + Caffeine (CA + C)
Number of subjects: 10
Study 27998025 — intervention group
Group type: EXPERIMENTAL
Intervention: TCA peel
Number of subjects: 30
Study 27998025 — intervention group
Group type: EXPERIMENTAL
Intervention: dermapen machine
Number of subjects: 30
Study 27998025 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study 27434441 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine implants (80 mg, 4 implants)
Number of subjects: 177
Study 27434441 — intervention group
Group type: COMPARATOR
Intervention: Sublingual buprenorphine (8 mg/d or less) with placebo implants
Number of subjects: 177
Study 24400915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 308
Study 24400915 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 308
Study 22241281 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg amisulpride
Number of subjects: 78
Study 22241281 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg aripiprazole
Number of subjects: 78
Study 22241281 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg haloperidol
Number of subjects: 78
Study 22241281 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg risperidone
Number of subjects: 78
Study 22241281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 18679683 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-impregnated wound dressing
Number of subjects: 601
Study 18679683 — intervention group
Group type: COMPARATOR
Intervention: Standard sterile dressing
Number of subjects: 601
Study 18665060 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians with higher openness to feelings
Number of subjects: 46
Study 18665060 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians who are more dutiful or rule-bound
Number of subjects: 46
Study 18665060 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians reporting more anxious vulnerability
Number of subjects: 46
Study 15569821 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) 10 microg/kg per day for 5 days
Number of subjects: 16
Study 15569821 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 16
Study 12572702 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose spiral computed tomography (CT) screening
Number of subjects: 0